Surprise! Pfizer And Lilly File Tanezumab For Pain With FDA Despite Safety Questions

 
• By Jessica Merrill
  
Surprise confetti
The prospects for tanezumab are uncertain • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapy Areas